• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>PML

PML

  1. All
  2. Morningstar Articles
  3. 3rd Party
  4. Investing
  1. Pivotal Data for Genentech Medicines in Lung and Blood Cancers to Be Presented at ASCO

    Pivotal Data for Genentech Medicines in Lung and Blood Cancers to Be Presented at ASCO

  2. New ibrutinib (IMBRUVICA®) Data to be Showcased at American Society of Clinical Oncology (ASCO) Annual Meeting

    New ibrutinib (IMBRUVICA®) Data to be Showcased at American Society of Clinical Oncology (ASCO) Annual Meeting

  3. Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates

    Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates

  4. Year in Review: Municipal CEFs

    We take a look at 2012's municipal CEF performance, distribution cuts, mergers, and more.

  5. A Closer Look at CEF Duration Risk

    An examination of 10 CEFs with the highest duration risk.

Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.